Compare IDEXX Laboratories, Inc. (IDXX) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Prudential Financial Inc — how do they compare? IDEXX Laboratories, Inc. trades at $556.84 (market cap $44.48B), while Prudential Financial Inc trades at $117.47 (market cap $40.97B). The key difference: IDEXX Laboratories, Inc. and Prudential Financial Inc are close in size by market cap, and Prudential Financial Inc pays a 4.75% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| IDXX | PRU | |
|---|---|---|
Market Cap | $44.48B | $40.97B |
Sector | Health | Financials |
52-Week High | $766.68 | $119.07 |
52-Week Low | $520.87 | $92.00 |
Enterprise Value | $45.38B | $68.03B |
Dividend Yield | — | 4.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Prudential Financial (PRU) trades at $118.04, down 0.87% on the day, showing mixed technical signals with a bullish overall trend but overbought RSI indicators. Fundamentally, the company demonstrates solid profitability with 5.5% net income margin and 11.08% ROE, though revenue declined from $70.7B in 2024 to $61.0B in 2025. Recent earnings show beats in Q3 2025 and Q1 2026, with Q2 2026 results expected August 4, 2026.
The stock presents a value opportunity with attractive valuation multiples (P/E 12.26, P/S 0.67) but faces headwinds from analyst skepticism (67.57% hold rating) and a consensus price target of $102.50 below current levels. Key risks include revenue volatility and high debt levels, while catalysts include retirement market growth and international expansion driving long-term earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
